Risk Management



ROP: laser surgery

LASER SURGERY FOR ROP

These forms were revised in August, 2018. Click on the links below to access the forms.

Consent for laser surgery to treat ROP

Consent for laser surgery to treat ROP.Spanish

Articles on neurodevelopment after Avastin (bevacizumab) injection

OMIC and our ROP Task Force want to let you know of some studies on the effect of Avastin on the infant’s neurodevelopment. We have revised our ROP consent forms to address this research.

Pediatrics published a report[1] showing that the odds of severe neurodevelopmental disabilities was 3.1 times higher in infants treated with Avastin than those treated with laser. Another article[2] showed increased odds only in infants treated with both Avastin and laser.

Research is ongoing to determine if Avastin and other anti-VEGF drugs are safe. In the meantime, we all have to explain what we do know about these drugs to parents whose infants need treatment for ROP.

Questions?

Please contact OMIC Patient Safety Manager Anne M. Menke, RN, PhD, if you have any questions about our ROP forms or recommendations. You may reach Anne at 415-202-4651 or at amenke@omic.com.

Please contact our confidential Risk Management Hotline if you need help developing or revising your protocols. You may email us at riskmanagement@omic.com or call 800-562-6642, option 4.

 

[1] Warren J, Luu TM, Superstein R, et al. Neurodevelopmental Outcomes Following Bevacizumab Injections for Retinopathy of Prematurity. Pediatrics. 2016; 137 (4): e20153218. http://pediatrics.aappublications.org/content/early/2016/03/16/peds.2015-3218

2 Lien R, Yu M-H, Hsu K-H, Liao P-J, Chen Y-P, Lai C-C, et al. (2016) Neurodevelopmental Outcomes in Infants with Retinopathy of Prematurity and Bevacizumab Treatment. PLoS ONE 11(1): e0148019. doi:10.1371/journal.pone.0148019. http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0148019

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment



Six reasons OMIC is the best choice for ophthalmologists in America.

#5. Expertise unmatched.

OMIC's sole mission is to serve ophthalmology. The premier source of ophthalmic claims data and loss prevention materials, OMIC's member hotline is the most used ophthalmic consultative service of its kind and OMIC.com is the most visited web site in America for ophthalmic risk management advice and patient consent documents.

61864684